Fosbretabulin free acid

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 584364

CAS#: 222030-63-9 (free acid)

Description: Fosbretabulin is a natural cis-stilbene which interferes with the cellular tubulin dynamics and which selectively destroys tumour blood vessels. Its pharmacological shortcomings such as insufficient chemical stability, water solubility, and cytotoxicity can be remedied by employing its imidazole derivatives.


Chemical Structure

img
Fosbretabulin free acid
CAS# 222030-63-9 (free acid)

Theoretical Analysis

MedKoo Cat#: 584364
Name: Fosbretabulin free acid
CAS#: 222030-63-9 (free acid)
Chemical Formula: C18H21O8P
Exact Mass: 396.10
Molecular Weight: 396.332
Elemental Analysis: C, 54.55; H, 5.34; O, 32.29; P, 7.82

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 168555-66-6 (disodium)   222030-63-9 (free acid)   404886-32-4 ( tromethamine),  

Synonym: Fosbretabulin; CA4DP; Combretastatin A-4

IUPAC/Chemical Name: Phenol, 2-methoxy-5-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate

InChi Key: WDOGQTQEKVLZIJ-WAYWQWQTSA-N

InChi Code: InChI=1S/C18H21O8P/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3/h5-11H,1-4H3,(H2,19,20,21)/b6-5-

SMILES Code: COC1=C(OC)C(OC)=CC(/C=C\C2=CC=C(OC)C(OP(O)(O)=O)=C2)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 396.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Mahal K, Biersack B, Caysa H, Schobert R, Mueller T. Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation. Invest New Drugs. 2015 Jun;33(3):541-54. doi: 10.1007/s10637-015-0215-9. Epub 2015 Feb 14. PubMed PMID: 25678082.

2: Wen Z, Xu J, Wang Z, Qi H, Xu Q, Bai Z, Zhang Q, Bao K, Wu Y, Zhang W. 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: microwave-assisted synthesis and biological evaluation. Eur J Med Chem. 2015 Jan 27;90:184-94. doi: 10.1016/j.ejmech.2014.11.024. Epub 2014 Nov 13. PubMed PMID: 25461319.

3: Méndez-Callejas GM, Leone S, Tanzarella C, Antoccia A. Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells. Cell Biol Int. 2014 Mar;38(3):296-308. doi: 10.1002/cbin.10199. Epub 2013 Nov 14. PubMed PMID: 24155061.

4: Madadi NR, Penthala NR, Howk K, Ketkar A, Eoff RL, Borrelli MJ, Crooks PA. Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4. Eur J Med Chem. 2015 Oct 20;103:123-32. doi: 10.1016/j.ejmech.2015.08.041. Epub 2015 Aug 29. PubMed PMID: 26352674; PubMed Central PMCID: PMC4631050.

5: Guan Q, Yang F, Guo D, Xu J, Jiang M, Liu C, Bao K, Wu Y, Zhang W. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4. Eur J Med Chem. 2014 Nov 24;87:1-9. doi: 10.1016/j.ejmech.2014.09.046. Epub 2014 Sep 16. PubMed PMID: 25233100.

6: Carvalho PC, Santos EA, Schneider BU, Matuo R, Pesarini JR, Cunha-Laura AL, Monreal AC, Lima DP, Antoniolli AC, Oliveira RJ. Diaryl sulfide analogs of combretastatin A-4: Toxicogenetic, immunomodulatory and apoptotic evaluations and prospects for use as a new chemotherapeutic drug. Environ Toxicol Pharmacol. 2015 Nov;40(3):715-21. doi: 10.1016/j.etap.2015.08.028. Epub 2015 Sep 2. PubMed PMID: 26410090.

7: Ma ZL, Yan XJ, Zhao L, Zhou JJ, Pang W, Kai ZP, Wu FH. Combretastatin A-4 and Derivatives: Potential Fungicides Targeting Fungal Tubulin. J Agric Food Chem. 2016 Feb 3;64(4):746-51. doi: 10.1021/acs.jafc.5b05119. Epub 2016 Jan 25. PubMed PMID: 26711170.

8: Xu Q, Qi H, Sun M, Zuo D, Jiang X, Wen Z, Wang Z, Wu Y, Zhang W. Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity. PLoS One. 2015 Jun 10;10(6):e0128710. doi: 10.1371/journal.pone.0128710. eCollection 2015. PubMed PMID: 26061410; PubMed Central PMCID: PMC4462585.

9: Torijano-Gutiérrez S, Vilanova C, Díaz-Oltra S, Murga J, Falomir E, Carda M, Redondo-Horcajo M, Díaz JF, Barasoain I, Marco JA. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin. Arch Pharm (Weinheim). 2015 Aug;348(8):541-7. doi: 10.1002/ardp.201500106. Epub 2015 Jun 17. PubMed PMID: 26085125.

10: Ke Q, Samad MA, Bae S, Chaplin DJ, Kang PM. Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem. Vascul Pharmacol. 2015 Nov;74:73-79. doi: 10.1016/j.vph.2015.05.004. Epub 2015 May 16. PubMed PMID: 25989107.

11: Sun J, Chen L, Liu C, Wang Z, Zuo D, Pan J, Qi H, Bao K, Wu Y, Zhang W. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4. Chem Biol Drug Des. 2015 Dec;86(6):1541-7. doi: 10.1111/cbdd.12617. Epub 2015 Sep 25. PubMed PMID: 26202587.

12: Gagné-Boulet M, Fortin S, Lacroix J, Lefebvre CA, Côté MF, C-Gaudreault R. Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model. Eur J Med Chem. 2015 Jul 15;100:34-43. doi: 10.1016/j.ejmech.2015.05.034. Epub 2015 May 28. PubMed PMID: 26069928.

13: Davydova MP, Sorokina IV, Tolstikova TG, Mamatyuk VI, Fadeev DS, Vasilevsky SF. [Synthesis of new analogues of combretastatin A-4 and the study of their anti-inflammatory activity]. Bioorg Khim. 2015 Jan-Feb;41(1):82-9. Russian. PubMed PMID: 26050475.

14: Vilanova C, Torijano-Gutiérrez S, Díaz-Oltra S, Murga J, Falomir E, Carda M, Alberto Marco J. Design and synthesis of pironetin analogue/combretastatin A-4 hybrids containing a 1,2,3-triazole ring and evaluation of their cytotoxic activity. Eur J Med Chem. 2014 Nov 24;87:125-30. doi: 10.1016/j.ejmech.2014.09.053. Epub 2014 Sep 16. PubMed PMID: 25240870.

15: Nkepang G, Bio M, Rajaputra P, Awuah SG, You Y. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor. Bioconjug Chem. 2014 Dec 17;25(12):2175-88. doi: 10.1021/bc500376j. Epub 2014 Nov 21. PubMed PMID: 25351441; PubMed Central PMCID: PMC4275160.

16: Rajak H, Dewangan PK, Patel V, Jain DK, Singh A, Veerasamy R, Sharma PC, Dixit A. Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers. Curr Pharm Des. 2013;19(10):1923-55. Review. PubMed PMID: 23237054.

17: Zhang C, Zhou SS, Li XR, Wang BM, Lin NM, Feng LY, Zhang DY, Zhang LH, Wang JB, Pan JP. Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo. Oncol Rep. 2013 Jun;29(6):2275-82. doi: 10.3892/or.2013.2405. Epub 2013 Apr 12. PubMed PMID: 23588374.

18: Yu K, Li R, Yang Z, Wang F, Wu W, Wang X, Nie C, Chen L. Discovery of a potent microtubule-targeting agent: Synthesis and biological evaluation of water-soluble amino acid prodrug of combretastatin A-4 derivatives. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2302-7. doi: 10.1016/j.bmcl.2015.04.028. Epub 2015 Apr 16. PubMed PMID: 25933592.

19: Jiang J, Zheng C, Zhu K, Liu J, Sun N, Wang C, Jiang H, Zhu J, Luo C, Zhou Y. Quantum chemistry calculation-aided structural optimization of combretastatin A-4-like tubulin polymerization inhibitors: improved stability and biological activity. J Med Chem. 2015 Mar 12;58(5):2538-46. doi: 10.1021/acs.jmedchem.5b00118. Epub 2015 Feb 26. PubMed PMID: 25689111.

20: Do CV, Faouzi A, Barette C, Farce A, Fauvarque MO, Colomb E, Catry L, Berthier-Vergnes O, Haftek M, Barret R, Lomberget T. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit. Bioorg Med Chem Lett. 2016 Jan 1;26(1):174-80. doi: 10.1016/j.bmcl.2015.11.010. Epub 2015 Nov 10. PubMed PMID: 26602281.